bicycle therapeutics | Bicycle Therapeutics

Keyword	CPC	PCC	Volume	Score	Length of keyword
bicycle therapeutics	0.2	0.2	491	35	20
bicycle	1.93	0.9	8415	33	7
therapeutics	0.14	0.5	4318	41	12

Keyword	CPC	PCC	Volume	Score
bicycle therapeutics	0.13	0.4	1614	60
bicycle therapeutics stock	1.31	0.5	2025	82
bicycle therapeutics share price	0.62	0.2	5391	61
bicycle therapeutics share	1.6	0.7	2090	62
bicycle therapeutics plc	0.3	0.3	8585	68
bicycle therapeutics pipeline	0.6	0.4	8819	56
bicycle therapeutics address	1.64	0.7	1075	8
bicycle therapeutics careers	1.3	0.9	5428	85
bicycle therapeutics logo	1.81	0.5	1676	47
bicycle therapeutics news	0.2	0.8	6278	49
bicycle therapeutics market cap	0.54	0.6	5310	11
bicycle therapeutics plc share price	1.94	1	4241	96
bicycle therapeutics stock price	0.88	0.8	4403	86
stephanie yao bicycle therapeutics	1.48	1	6903	76
kevin lee bicycle therapeutics	1.53	0.5	4207	5
when did bicycle therapeutics go public	1.02	0.9	187	80

Search Results related to bicycle therapeutics on Search Engine

Bicycle Therapeutics
bicycletherapeutics.com

https://www.bicycletherapeutics.com/

WEBBicycle is developing precision-guided therapeutics, to penetrate deep into tissues and target intractable cancers. Discover. Proposition. We have a clear mission: to create unique, impactful medicines that transform the lives of the largest possible number of patients. Programs. .

DA: 51 PA: 26 MOZ Rank: 17

Bicycle Therapeutics plc (BCYC) Stock Price, News, Quote
yahoo.com

https://finance.yahoo.com/quote/BCYC/

WEBBicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the...

DA: 12 PA: 20 MOZ Rank: 10

Bicycle Therapeutics | LinkedIn
linkedin.com

https://www.linkedin.com/company/bicycle-therapeutics/

WEBBicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing...

DA: 20 PA: 67 MOZ Rank: 83

Overview | Bicycle Therapeutics
bicycletherapeutics.com

https://investors.bicycletherapeutics.com/

WEBFeb 20, 2024 · Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results. View More. The Investor Relations website contains information about Bicycle Therapeutics's business for stockholders, potential investors, and financial analysts.

DA: 4 PA: 86 MOZ Rank: 64

Bicycle Therapeutics - Story - Bicycle Therapeutics
bicycletherapeutics.com

https://www.bicycletherapeutics.com/profile/story/

WEBThe Bicycle technology arose from research by Sir Greg Winter, winner of the Nobel Prize in Chemistry in 2018 for his pioneering work in phage display. This technology has led to major therapeutic advances in antibody based therapeutics; and bicyclic peptide (Bicycle) drug discovery and development.

DA: 1 PA: 44 MOZ Rank: 2

Bicycle Therapeutics Announces Continued Clinical Progress and …
businesswire.com

https://www.businesswire.com/news/home/20220105005201/en/Bicycle-Therapeutics-Announces-Continued-Clinical-Progress-and-Updates-to-Management-Team

WEBJan 5, 2022 · Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing...

DA: 90 PA: 13 MOZ Rank: 35

Bicycle Therapeutics - Pipeline - Bicycle Therapeutics
bicycletherapeutics.com

https://www.bicycletherapeutics.com/pipeline/pipeline/

WEBBicycles are a novel molecule formed by constraining short linear peptides into a stabilized bi-cyclic structure using a central chemical scaffold. The resulting structure enables Bicycles to effectively mimic protein-protein interactions.

DA: 10 PA: 81 MOZ Rank: 91

Bicycle Therapeutics Announces Pipeline Progress Update
businesswire.com

https://www.businesswire.com/news/home/20210114005302/en/Bicycle-Therapeutics-Announces-Pipeline-Progress-Update

WEBJan 14, 2021 · CAMBRIDGE, England & BOSTON-- ( BUSINESS WIRE )-- Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its...

DA: 85 PA: 73 MOZ Rank: 27

Bicycle Therapeutics Reports Third Quarter 2021 Financial …
bicycletherapeutics.com

https://investors.bicycletherapeutics.com/news-releases/news-release-details/bicycle-therapeutics-reports-third-quarter-2021-financial

WEBNov 4, 2021 · CAMBRIDGE, England, & BOSTON -- (BUSINESS WIRE)--Nov. 4, 2021-- Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide ( Bicycle®) technology, today reported financial results for the third quarter ended September 30, …

DA: 28 PA: 73 MOZ Rank: 25

Bicycle Therapeutics Announces Significant Progress Across …
bicycletherapeutics.com

https://investors.bicycletherapeutics.com/news-releases/news-release-details/bicycle-therapeutics-announces-significant-progress-across/

WEBMar 30, 2021 · Bicycle Therapeutics (NASDAQ: BCYC) is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics.

DA: 6 PA: 64 MOZ Rank: 21